UNITE WITH 100+ OV TRAILBLAIZERS ACROSS SESSIONS SPANNING EARLY DISCOVERY, TRANSLATION, CLINICAL DEVELOPMENT, CHEMISTRY, MANUFACTURING & CONTROLS (CMC), AND REGULATIONS TO OVERCOME THE INDUSTRY’S LARGEST AND CRITICAL BOTTLENECKS.

Register Today to meet the team in Boston.

Presentation by Elie Hanania, Ph.D. VP Process Development Viral Vector

• Presentation Date: Thursday, December 14th at 3:00 pm
• Production, Purification, & Characterization of Oncolytic Herpes Simplex Virus for Viro-Oncotherapies
• More details can be found of the presentation here